Fenway Health Successfully Renews Patient Centered Medical Home Recognition and Distinction in Behavioral Health Integration
We are very happy to share that Fenway has once again successfully renewed our NCQA Patient Centered Medical Home (PCMH) Recognition for our location at
Coming Soon: YEZTUGO, the First Twice-Yearly Injectable PrEP
Fenway Health is proud to share that the FDA has just approved YEZTUGO, the first long-acting injectable PrEP medication administered just twice a year. This is
Fenway Health Commends Supreme Court Braidwood Decision Preserving Access to PrEP & Other Preventive Care
Fenway Health joins healthcare organizations across the country in commending the Supreme Court’s decision in Kennedy v. Braidwood to protect Affordable Care Act (ACA) requirements
Fenway Health Only New England Site Involved in Study Demonstrating Efficacy of Lenacapravir Twice-Yearly PrEP Injection
On June 18, the US Food and Drug Administration (FDA) approved the use of Gilead’s anti-HIV medication, Lenacapravir (trade name: Yeztugo) as a twice-yearly subcutaneous
Fenway Health Statement on Supreme Court U.S. v Skrmetti Decision
The Supreme Court of the United States issued a decision today in U.S. v Skrmetti to uphold Tennessee’s discriminatory ban on evidence-based, life-saving care for
Celebrating Juneteenth 2025
Juneteenth is the oldest national day marking the end of slavery in the United States. On June 19, 1865, Union Major General Gordon Granger reached
The Fenway Institute Releases New Toolkit to Advance LGBTQIA+ Inclusion in Clinical Research
The Fenway Institute released Creating Welcoming and Affirming Clinical Studies for LGBTQIA+ Participants, a free, multi-component toolkit to help advance LGBTQIA+ inclusion in clinical research
This Year, Pride Isn’t Just a Time to Celebrate, It’s a Time to Mobilize
At Fenway Health, we take Pride in Our Health. Celebrate Pride with us! Support Fenway Health and show your LGBTQIA+ Pride with our 2025 Pride